Aliquots of Reference Molecules

& Monoclonal Antibody Drugs

Buy as Consumables | Multiple batches are available

Drug aliquots of more than 20 different reference drugs (EU) are available in stock, all of them contain therapeutic monoclonal antibodies as the active ingredient. The drug aliquots are in their clinical use concentration and buffer and, are intended exclusively for use in research and development.

Our Products(Reference Drugs as Aliquots)	Antigen	Drug Brand	CoA availability
Adalimumab drug aliquots	TNF-α	Humira ^®	yes	Select options
Aflibercept drug aliquots	VEGF-A	Eylea ^®	no	Select options
Aldesleukin drug aliquots	IL-2 RB	Proleukin ^®	no	Select options
Atezolizumab drug aliquots	PD-L1	Tecentriq ^®	yes	Select options
Avelumab drug aliquots	PD-L1	Bavencio ^®	no	Select options
Bevacizumab drug aliquots	VEGF-A	Avastin ^®	no ⋅ yes	Select options
Cetuximab drug aliquots	EGFR	Erbitux ^®	no	Select options
Daratumumab drug aliquots	CD38	Darzalex ^®	no	Select options
Denosumab drug aliquots	RANKL	Prolia ^®	no	Select options
Dinutuximab beta drug aliquots	GD2	Qarziba ^®	no	Select options
Durvalumab drug aliquots	PD-L1	Imfinzi ^®	no	Select options
Elotuzumab drug aliquots	SLAM	Empliciti ^®	no	Select options
Emicizumab drug aliquots	Clotting Factor IXa and X	Hemlibra ^®	no	Select options
Epoetin zeta (Biosimilar) drug aliquots	Erythroid growth factor	Silapo 160000 ^®	no	Select options
Etanercept drug aliquots	TNF-α	Enbrel ^®	no	Select options
Golimumab drug aliquots	TNF-α	Simponi ^®	no	Select options
Guselkumab drug aliquots	IL-23	Tremfya ^®	no	Select options
Infliximab drug aliquots	TNF-α	Remicade ^®	no	Select options
Ipilimumab drug aliquots	CD152 ⋅ CTLA4	Yervoy ^®	yes	Select options
Nivolumab drug aliquots	PD-1	Opdivo ^®	no	Select options
Obinutuzumab drug aliquots	CD20	Gazyvaro ^®	no	Select options
Ocrelizumab drug aliquots	CD20	Ocrevus(R) ^®	no ⋅ yes	Select options
Palivizumab drug aliquots	RSV protein F	Synagis ^®	yes	Select options
Pembrolizumab drug aliquots	PD-1	Keytruda ^®	no ⋅ yes	Select options
Pertuzumab drug aliquots	HER2	Perjeta ^®	yes	Select options
Ramucirumab drug aliquots	VEGFR2	Cyramza ^®	no	Select options
Risankizumab drug aliquots	IL-23	Skyrizi ^®	yes	Select options
Rituximab drug aliquots	CD20	Mabthera ^®	no ⋅ yes	Select options
Romiplostim drug aliquots	Thrombopoietin receptor	NPlate ^®	no	Select options
Secukinumab drug aliquots	IL 17A	Cosentyx ^®	no ⋅	Select options
Tocilizumab drug aliquots	IL-6 R	RoActemra ^®	no	Select options
Trastuzumab drug aliquots	HER2	Herceptin ^®	no	Select options
Ustekinumab drug aliquots	IL-12	Stelara ^®	no	Select options

Certificate of Analysis (CofA)

for Monoclonal Antibody Drugs

Certificate of Analysis | Original Batch Documentation

Certificate of Analysis (CofA) is an official document issued by the manufacturer of the medicinal product. It contains information on some critical quality characteristics of the medicine. Customers can order the medicinal product CoA together with the drug aliquots of the same batch. A listing of all available CofAs corresponding to the batches of drug aliquots available can be found below.

Certificate of Analysis(from reference drug manufacturer)	Batch Number	Expiry Date	Price
CoA – Avastin \| Bevacizumab \| VEGF-A \| B8800H28	B8800H28	03/2021	150,00 €	Buy
CoA – Humira \| Adalimumab \| TNF-α \| 02006LX02	02006LX02	01/2021	150,00 €	Buy
CoA – Humira \| Adalimumab \| TNF-α \| 040309A07	040309A07	03/2021	150,00 €	Buy
CoA – Humira \| Adalimumab \| TNF-α \| 70225XH07	70225XH07	09/2018	150,00 €	Buy
CoA – Humira \| Adalimumab \| TNF-α \| 73254XH03	73254XH03	12/2018	150,00 €	Buy
CoA – Humira \| Adalimumab \| TNF-α \| 76287XH07	76287XH07	03/2019	150,00 €	Buy
CoA – Humira \| Adalimumab \| TNF-α \| 76287XH11	76287XH11	03/2019	150,00 €	Buy
CoA – Humira \| Adalimumab \| TNF-α \| 80315XH04	80315XH04	07/2019	150,00 €	Buy
CoA – Humira \| Adalimumab \| TNF-α \| 85364XH07	85364XH07	12/2019	150,00 €	Buy
CoA – Humira \| Adalimumab \| TNF-α \| 88400XH01	88400XH01	03/2020	150,00 €	Buy
CoA – Mabthera \| Rituximab \| CD20 \| N7438B09	N7438B09	02/2023	150,00 €	Buy
CoA – Perjeta \| Pertuzumab \| HER2 \| H0332H02	H0332H02	11/2020	150,00 €	Buy
CoA – Skyrizi \| Risankizumab \| IL23 \| 1124728	1124728	06/2021	150,00 €	Buy
CoA – Stelara \| Ustekinumab \| IL-12 \| JKS2Gxx	inquire for details	10/2022	150,00 €	Buy
CoA – Stelara \| Ustekinumab \| IL-12 \| JKS2Gxy	inquire for details	10/2022	150,00 €	Buy
CoA – Stelara \| Ustekinumab \| IL-12 \| KCS11xx	inquire for details	02/2023	150,00 €	Buy
CoA – Synagis \| Palivizumab \| RSV protein F \| 382291	382291	04/2019	150,00 €	Buy
CoA – Synagis \| Palivizumab \| RSV protein F \| 382445	382445	06/2019	150,00 €	Buy
CoA – Synagis \| Palivizumab \| RSV protein F \| 382615	382615	10/2019	150,00 €	Buy
CoA – Synagis \| Palivizumab \| RSV protein F \| 382683	382683	02/2020	150,00 €	Buy
CoA – Synagis \| Palivizumab \| RSV protein F \| 382835	382835	08/2020	150,00 €	Buy
CoA – Tecentriq \| Atezolizumab \| PD-L1 \| B0006B01	B0006B01	03/2022	150,00 €	Buy
CoA – Yervoy \| Ipilimumab \| CD152 / CTLA4 \| ABE0468	ABE0468	08/2021	150,00 €	Buy